ÃÛÌÒ´«Ã½ Cares: A force for good
ÃÛÌÒ´«Ã½ Cares expresses our passion for helping others and our pledge to achieve more together. With our large global workforce, we see this as an immense opportunity to use our knowledge, experience and kindness towards others as forces for good.
At ÃÛÌÒ´«Ã½, we are passionate about:
- Creating a positive impact on patients¡¯ lives and applying our collective expertise and innovation to increase access to clinical trials across all populations and thereby drive better patient outcomes
- Conducting business sustainably and playing a role in combating climate change
- Promoting our employees¡¯ professional development and creating a workplace where all employees feel a sense of belonging and can contribute to our mission
- Strengthening the communities in which we live and work
- Doing the right thing
ÃÛÌÒ´«Ã½ Cares 2024 Report - A message from Steve Cutler, our CEO
Throughout 2024, ÃÛÌÒ´«Ã½ remained focused on its mission of expediting drug development to improve patients¡¯ lives.
The industry sits at the confluence of the artificial intelligence (AI) revolution and a parallel revolution in biomedical science. This represents an unprecedented opportunity to address unmet clinical need and to impact the lives of countless patients.
As a leading clinical research organisation (CRO), we strive for better patient outcomes while making a significant impact on improving access to clinical trials on a larger scale. This entails conducting our business sustainably, fostering an inclusive workplace for all employees and supporting the wellbeing of our communities ¨C all with an emphasis on collaboration.
In 2024 we contributed to 19 medicines. We concentrated on expanding trial access for all participants, trial investigators and community and patient advocacy groups. We expanded our capabilities in AI and robotic process automation, which in turn enhanced our efficiency, execution and delivery for our customers. Our science-based targets (SBTs) were also validated in October 2024. With this validation complete and our software platform in place to help collect and monitor our emissions, ÃÛÌÒ´«Ã½ has a solid foundation for working towards achieving our climate targets in the years to come.
While we take pride in what we¡¯ve accomplished, we will not become complacent. Looking to and beyond 2025, we will sharpen our focus on learning, growing and transforming as a CRO partner of choice. We will intensify our pursuit of novel processes with patient care at the centre. We will continue to optimise clinical operations, synthesising with our data, expertise, experience, insights and technology. We will drive progress, guided by our collective vision for ÃÛÌÒ´«Ã½ Cares.
Kind regards,
Steve Cutler
Chief Executive Officer
Download the ÃÛÌÒ´«Ã½ Cares 2024 report
Our ÃÛÌÒ´«Ã½ Cares goals
ICON is a signatory of the and a regular participant in EcoVadis and CDP assessments. ÃÛÌÒ´«Ã½ reports in alignment with the Global Reporting Initiative (GRI), the International Financial Reporting Standards (IFRS) S2, the Sustainability Accounting Standards Board (SASB) and the . In 2024, our near-term, long-term and net-zero science-based targets (SBTs) were validated by the SBTi based on our submission. We report on our targets and progress towards them for the first time in our 2024 ÃÛÌÒ´«Ã½ Cares report.
Reports
Historical reports
- ÃÛÌÒ´«Ã½ - | | | |
- PRA - | | | |
EY assurance
Carbon Trust assurances
- | |
California climate disclosure in accordance with AB 1305
Our ÃÛÌÒ´«Ã½ Cares priorities
ÃÛÌÒ´«Ã½ Cares strives to drive meaningful change for our global workforce, the communities where we operate, the environment and the wider society.
ÃÛÌÒ´«Ã½ previously identified seven key ESG priorities which are focus areas for us in managing impacts on our business, people, the environment and communities. In 2024, the Science-Based Target initiative (SBTi) verified ÃÛÌÒ´«Ã½¡¯s near-term, long-term and net-zero targets. This milestone will drive ÃÛÌÒ´«Ã½¡¯s climate strategy in the years to come.
2024 PwC Business Post Sustainable Business Awards
ÃÛÌÒ´«Ã½ has been named Social & Equality Business of the Year at the These awards recognise leadership, innovation, investment and ingenuity in the areas of Environment, Social and Governance.
Frost & Sullivan Enlightened Growth Leadership Award
The Frost & Sullivan Institute presented ÃÛÌÒ´«Ã½ with an in both 2024 and 2023.
The awards identify companies that have embraced emerging technologies, generated opportunities for all, while demonstrating best practices for sustainable growth.
AmCham Global Impact Award
ÃÛÌÒ´«Ã½ received the 2023 at the American Chamber of Commerce Ireland¡¯s US-Ireland Business Awards.
Those shortlisted for the Global Impact Award were required to have had a positive, global or international impact on markets or society, and to demonstrate a commitment to inclusion and diversity.
